Monday, October 16, 2017 10:15 PM ET
Insiders Make Significant purchases of KalVista Pharmaceuticals (KALV) Shares Reversing the 90 day Selling Trend
KalVista Pharmaceuticals insider trading represents a higher number of buy/sell transactions than for the 42 peer company average over the last 90-day period. The Biopharmaceuticals peer group saw 26 buy/sell trades during this period for an average of 0.6 transactions per company. The number of shares per buy/sell trade for KalVista Pharmaceuticals insiders was also higher. Within the peer group there were 44,500 shares purchased and 3,714,825 shares sold with company insiders having sold 141,166 shares on average.
The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* RA CAPITAL MANAGEMENT, LLC, 10% Owner and Director, bought 850,000 shares
* Rajeev M. Shah, 10% Owner and Director, bought 850,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.